BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9132315)

  • 1. Methotrexate related cutaneous vasculitis.
    Torner O; Ruber C; Olive A; Tena X
    Clin Rheumatol; 1997 Jan; 16(1):108-9. PubMed ID: 9132315
    [No Abstract]   [Full Text] [Related]  

  • 2. Leukocytoclastic vasculitis induced by low-dose methotrexate: in vitro evidence for an immunologic mechanism.
    Halevy S; Giryes H; Avinoach I; Livni E; Sukenik S
    J Eur Acad Dermatol Venereol; 1998 Jan; 10(1):81-5. PubMed ID: 9552765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous necrotizing vasculitis after low dose methotrexate therapy for rheumatoid arthritis: a possible manifestation of methotrexate hypersensitivity.
    Simonart T; Durez P; Margaux J; Van Geertruyden J; Goldschmidt D; Parent D
    Clin Rheumatol; 1997 Nov; 16(6):623-5. PubMed ID: 9456017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nodular efflorescence and cutaneous vasculitis in rheumatoid arthritis treated with methotrexate].
    Lassoued S; Billey T; Pages M; Dromer C; Fournie B; Fournie A
    Presse Med; 1992 Mar; 21(9):437. PubMed ID: 1533038
    [No Abstract]   [Full Text] [Related]  

  • 5. Cutaneous vasculitis associated with infliximab in the treatment of rheumatoid arthritis.
    Anandacoomarasamy A; Kannangara S; Barnsley L
    Intern Med J; 2005 Oct; 35(10):638-40. PubMed ID: 16207269
    [No Abstract]   [Full Text] [Related]  

  • 6. Tocilizumab-induced leucocytoclastic vasculitis in a patient with rheumatoid arthritis.
    Sakaue S; Sumitomo S; Kubo K; Fujio K; Yamamoto K
    Rheumatology (Oxford); 2014 Aug; 53(8):1529-30. PubMed ID: 24609062
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term follow-up of 453 rheumatoid arthritis patients treated with methotrexate: an open, retrospective, observational study.
    Bologna C; Viu P; Picot MC; Jorgensen C; Sany J
    Br J Rheumatol; 1997 May; 36(5):535-40. PubMed ID: 9189054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digital vasculitis with eosinophilia possibly associated with etanercept therapy.
    Nakahigashi K; Egawa G; Miyachi Y; Kabashima K
    Acta Derm Venereol; 2014 Mar; 94(2):239-40. PubMed ID: 23824408
    [No Abstract]   [Full Text] [Related]  

  • 9. Demyelinating disease and cutaneous lymphocitic vasculitis after etanercept therapy in a patient with rheumatoid arthritis.
    Clemente RE
    Scand J Rheumatol; 2007; 36(3):244-5; author reply 245. PubMed ID: 17657687
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cutaneous lymphoma associated with methotrexate in a patient with rheumatoid arthritis].
    Antón Vázquez V; Corominas H; García Muñoz N; Hebe Petiti G
    Farm Hosp; 2018 Jan; 42(1):35-36. PubMed ID: 29306316
    [No Abstract]   [Full Text] [Related]  

  • 11. Leukocytoclastic Vasculitis and Dermal Perivascular Hemophagocytosis Associated With Adalimumab Therapy for Rheumatoid Arthritis.
    Muto J; Usami J; Watanabe D
    Am J Dermatopathol; 2018 Jan; 40(1):57-59. PubMed ID: 28719435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocytoclastic vasculitis due to etanercept.
    Galaria NA; Werth VP; Schumacher HR
    J Rheumatol; 2000 Aug; 27(8):2041-4. PubMed ID: 10955351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab-induced vasculitis: A case report and review of the medical published work.
    Kim MJ; Kim HO; Kim HY; Park YM
    J Dermatol; 2009 May; 36(5):284-7. PubMed ID: 19382999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demyelinating disease and cutaneous lymphocitic vasculitis after etanercept therapy in a patient with rheumatoid arthritis.
    Martínez-Taboada VM; Val-Bernal JF; Pesquera LC; Fernández-Llanio NE; Esteban JM; Blanco R; Alonso-Bartolome P; Gonzalez-Vela C; Rodríguez-Valverde V
    Scand J Rheumatol; 2006; 35(4):322-3. PubMed ID: 16882599
    [No Abstract]   [Full Text] [Related]  

  • 15. Cutaneous vasculitis induced by TNF inhibitors: a report of three cases.
    Fujikawa K; Kawakami A; Hayashi T; Iwamoto N; Kawashiri SY; Aramaki T; Ichinose K; Tamai M; Arima K; Kamachi M; Yamasaki S; Nakamura H; Ida H; Origuchi T; Eguchi K
    Mod Rheumatol; 2010 Feb; 20(1):86-9. PubMed ID: 19812889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab-induced vasculitis.
    Dereure O; Navarro R; Rossi JF; Guilhou JJ
    Dermatology; 2001; 203(1):83-4. PubMed ID: 11549810
    [No Abstract]   [Full Text] [Related]  

  • 17. Leukocytoclastic vasculitis associated with sotalol therapy.
    Rustmann WC; Carpenter MT; Harmon C; Botti CF
    J Am Acad Dermatol; 1998 Jan; 38(1):111-2. PubMed ID: 9448217
    [No Abstract]   [Full Text] [Related]  

  • 18. Cutaneous lymphocytic vasculitis during TNFalpha antagonist therapy for polyarthritis.
    Wendling D; Streit G; Lehuédé G; Toussirot E; Aubin A; Petitjean A
    Joint Bone Spine; 2006 Mar; 73(2):215-6. PubMed ID: 16213773
    [No Abstract]   [Full Text] [Related]  

  • 19. Accelerated cutaneous nodulosis during methotrexate therapy in a patient with rheumatoid arthritis.
    Williams FM; Cohen PR; Arnett FC
    J Am Acad Dermatol; 1998 Aug; 39(2 Pt 2):359-62. PubMed ID: 9703153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nodulosis during methotrexate therapy for rheumatoid arthritis.
    Das SK; Kumar A
    J Assoc Physicians India; 1995 Sep; 43(9):651. PubMed ID: 8773077
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.